{"id":"W4292121937","doi":"10.1007/s00432-022-04189-6","title":"Triple negative breast cancer: approved treatment options and their mechanisms of action","year":2022,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Triple-negative breast cancer; Epirubicin; Olaparib; Breast cancer; Oncology; Docetaxel; Paclitaxel; Internal medicine; Adverse effect; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003773883,0.0001185784,0.0008053797,0.0003019506,0.0002431351,0.00001489637,0.000157063,0.0001292173,0.0009814936],"category_scores_gemma":[0.0003326914,0.00008013048,0.0001711426,0.0004107061,0.0006137667,0.00007909962,0.0001844975,0.001442852,7.490255e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001476546,"about_ca_system_score_gemma":0.004208394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002230135,"about_ca_topic_score_gemma":0.001404432,"domain_scores_codex":[0.9967444,0.001095574,0.0008225517,0.0002567077,0.0007011206,0.000379624],"domain_scores_gemma":[0.9965059,0.001566944,0.0004064793,0.0001706948,0.0008524588,0.0004975076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02377572,0.003330294,0.01737482,0.0001503117,0.001381192,0.0001609515,0.0009173329,0.00003170242,0.01677813,0.0008465966,0.007034665,0.9282183],"study_design_scores_gemma":[0.06564298,0.2567686,0.2312837,0.0006957793,0.0008484695,0.003197829,0.03106163,0.002215393,0.02408409,0.03552186,0.3480898,0.0005898664],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9392458,0.006137777,0.0001290773,0.05182256,0.0007313423,0.0009798958,0.0002750443,0.000008167885,0.0006703382],"genre_scores_gemma":[0.9348031,0.06259411,0.0003653888,0.0002375694,0.0006070541,0.0002253221,0.000002522032,0.0000203534,0.001144627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9276284,"threshold_uncertainty_score":0.9999318,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3171317950564267,"score_gpt":0.5861197862775303,"score_spread":0.2689879912211036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}